Prostate cancer Board decisions

The Board granted service connection for a heart condition manifest by cardiac arrhythmia, diabetes mellitus, type II, prostate cancer, hypertension, and eczema based on presumptive exposure to herbicide agents during active service.

The Board remands the claims for service connection for a heart disability and prostate cancer due to insufficient efforts in obtaining necessary documentation.

The Board denied service connection for prostate cancer and erectile dysfunction, finding the evidence did not support a link to the Veteran's active duty service.

The Board granted service connection for hypertension, multiple myeloma, prostate cancer, hypothyroidism, and a heart condition as secondary to service-connected hypertension due to herbicide exposure.

The appeal for an initial rating in excess of 30 percent for coronary artery disease was dismissed, and the effective date for service connection for both coronary artery disease and prostate cancer residuals could not be earlier than September 27, 2021.

The Board denied the veteran's claims for increased ratings and dismissed the appeal regarding an earlier effective date for a TDIU as moot.

The Board denied the Veteran's claim for service connection for prostate cancer, finding no medical evidence linking his condition to his active-duty service.

The appeal for service connection for hypertension and prostate cancer/residuals thereof was dismissed as the Veteran opted into the Appeals Modernization Act (AMA) review system within 60 days after issuance of a May 2025 supplemental statement of the case.

The Veteran withdrew his appeals for service connection for persistent sinusitis, rhinitis, and prostate cancer.

The Board granted service connection for prostate cancer and erectile dysfunction, secondary to the now service-connected prostate cancer, but denied service connection for an acquired psychiatric disorder.

The Board granted a permanent and total rating for the Veteran's service-connected prostate cancer based on evidence showing it is unlikely to improve.

The Board remands the claims for service connection for heart and prostate disabilities to ensure that VA has met its duty to assist by obtaining outstanding private medical treatment records.

The Board granted service connection for chronic kidney disease stage 3 and prostate cancer, resolving reasonable doubt in the Veteran's favor based on a private medical opinion.

The Board granted service connection for diabetes mellitus type 2, Parkinson's disease, hypertension (under the PACT Act), prostate cancer, and erectile dysfunction. The claims for anemia, insomnia, and Alzheimer's disease were remanded.

The Board granted service connection for prostate cancer under the PACT Act and a 30 percent rating for tension headaches, while remanding another claim for further development.

The Board denied the veteran's claims for increased ratings and remanded several other issues, including a claim for TDIU.

The appeal concerning the issue of entitlement to service connection for prostate cancer was dismissed due to a timely filed NOD.

The Board denied the Veteran's claim for an initial rating in excess of 40 percent for residuals of prostate cancer, as there was no evidence that urine leakage required the use of an appliance or absorbent materials changed more than four times per day.

The appeal for increased ratings and other benefits related to the Veteran's service-connected conditions was dismissed due to the Veteran's death before any claims were finally adjudicated.

The Board remands the issues of service connection for diabetes, hypertension, and prostate cancer to correct a duty to assist error related to notice of the Veteran's right to a hearing before the AOJ.